Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training

M. Nemec, L. Vernerová, N. Laiferová, M. Balážová, M. Vokurková, T. Kurdiová, S. Oreská, K. Kubínová, M. Klein, M. Špiritović, M. Tomčík, J. Vencovský, J. Ukropec, B. Ukropcová

. 2021 ; 599 (1) : 207-229. [pub] 20201104

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NV16-33574A MZ0 CEP Register

Digital library NLK
Full text - Article

E-resources Online Full text

NLK Free Medical Journals from 1878 to 1 year ago
PubMed Central from 1878 to 1 year ago
Wiley Free Content from 1997 to 1 year ago

KEY POINTS: Regular exercise improves muscle functional capacity and clinical state of patients with idiopathic inflammatory myopathy (IIM). In our study, we used an in vitro model of human primary muscle cell cultures, derived from IIM patients before and after a 6-month intensive supervised training intervention to assess the impact of disease and exercise on lipid metabolism dynamics. We provide evidence that muscle cells from IIM patients display altered dynamics of lipid metabolism and impaired adaptive response to saturated fatty acid load compared to healthy controls. A 6-month intensive supervised exercise training intervention in patients with IIM mitigated disease effects in their cultured muscle cells, improving or normalizing their capacity to handle lipids. These findings highlight the putative role of intrinsic metabolic defects of skeletal muscle in the pathogenesis of IIM and the positive impact of exercise, maintained in vitro by yet unknown epigenetic mechanisms. ABSTRACT: Exercise improves skeletal muscle function, clinical state and quality of life in patients with idiopathic inflammatory myopathy (IIM). Our aim was to identify disease-related metabolic perturbations and the impact of exercise in skeletal muscle cells of IIM patients. Patients underwent a 6-month intensive supervised training intervention. Muscle function, anthropometric and metabolic parameters were examined and muscle cell cultures were established (m. vastus lateralis; Bergström needle biopsy) before and after training from patients and sedentary age/sex/body mass index-matched controls. [14 C]Palmitate was used to determine fat oxidation and lipid synthesis (thin layer chromatography). Cells were exposed to a chronic (3 days) and acute (3 h) metabolic challenge (the saturated fatty acid palmitate, 100 μm). Reduced oxidative (intermediate metabolites, -49%, P = 0.034) and non-oxidative (diglycerides, -38%, P = 0.013) lipid metabolism was identified in palmitate-treated muscle cells from IIM patients compared to controls. Three days of palmitate exposure elicited distinct regulation of oxidative phosphorylation (OxPHOS) complex IV and complex V/ATP synthase (P = 0.012/0.005) and adipose triglyceride lipase in patients compared to controls (P = 0.045) (immunoblotting). Importantly, 6 months of training in IIM patients improved lipid metabolism (CO2 , P = 0.010; intermediate metabolites, P = 0.041) and activation of AMP kinase (P = 0.007), and nearly normalized palmitate-induced changes in OxPHOS proteins in myotubes from IIM patients, in parallel with improvements of patients' clinical state. Myotubes from IIM patients displayed altered dynamics of lipid metabolism and impaired response to metabolic challenge with saturated fatty acid. Our observations suggest that metabolic defects intrinsic to skeletal muscle could represent non-immune pathomechanisms, which can contribute to muscle weakness in IIM. A 6-month training intervention mitigated disease effects in muscle cells in vitro, indicating the existence of epigenetic regulatory mechanisms.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019562
003      
CZ-PrNML
005      
20210830101146.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1113/JP280468 $2 doi
035    __
$a (PubMed)33063873
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Nemec, M $u Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia
245    10
$a Altered dynamics of lipid metabolism in muscle cells from patients with idiopathic inflammatory myopathy is ameliorated by 6 months of training / $c M. Nemec, L. Vernerová, N. Laiferová, M. Balážová, M. Vokurková, T. Kurdiová, S. Oreská, K. Kubínová, M. Klein, M. Špiritović, M. Tomčík, J. Vencovský, J. Ukropec, B. Ukropcová
520    9_
$a KEY POINTS: Regular exercise improves muscle functional capacity and clinical state of patients with idiopathic inflammatory myopathy (IIM). In our study, we used an in vitro model of human primary muscle cell cultures, derived from IIM patients before and after a 6-month intensive supervised training intervention to assess the impact of disease and exercise on lipid metabolism dynamics. We provide evidence that muscle cells from IIM patients display altered dynamics of lipid metabolism and impaired adaptive response to saturated fatty acid load compared to healthy controls. A 6-month intensive supervised exercise training intervention in patients with IIM mitigated disease effects in their cultured muscle cells, improving or normalizing their capacity to handle lipids. These findings highlight the putative role of intrinsic metabolic defects of skeletal muscle in the pathogenesis of IIM and the positive impact of exercise, maintained in vitro by yet unknown epigenetic mechanisms. ABSTRACT: Exercise improves skeletal muscle function, clinical state and quality of life in patients with idiopathic inflammatory myopathy (IIM). Our aim was to identify disease-related metabolic perturbations and the impact of exercise in skeletal muscle cells of IIM patients. Patients underwent a 6-month intensive supervised training intervention. Muscle function, anthropometric and metabolic parameters were examined and muscle cell cultures were established (m. vastus lateralis; Bergström needle biopsy) before and after training from patients and sedentary age/sex/body mass index-matched controls. [14 C]Palmitate was used to determine fat oxidation and lipid synthesis (thin layer chromatography). Cells were exposed to a chronic (3 days) and acute (3 h) metabolic challenge (the saturated fatty acid palmitate, 100 μm). Reduced oxidative (intermediate metabolites, -49%, P = 0.034) and non-oxidative (diglycerides, -38%, P = 0.013) lipid metabolism was identified in palmitate-treated muscle cells from IIM patients compared to controls. Three days of palmitate exposure elicited distinct regulation of oxidative phosphorylation (OxPHOS) complex IV and complex V/ATP synthase (P = 0.012/0.005) and adipose triglyceride lipase in patients compared to controls (P = 0.045) (immunoblotting). Importantly, 6 months of training in IIM patients improved lipid metabolism (CO2 , P = 0.010; intermediate metabolites, P = 0.041) and activation of AMP kinase (P = 0.007), and nearly normalized palmitate-induced changes in OxPHOS proteins in myotubes from IIM patients, in parallel with improvements of patients' clinical state. Myotubes from IIM patients displayed altered dynamics of lipid metabolism and impaired response to metabolic challenge with saturated fatty acid. Our observations suggest that metabolic defects intrinsic to skeletal muscle could represent non-immune pathomechanisms, which can contribute to muscle weakness in IIM. A 6-month training intervention mitigated disease effects in muscle cells in vitro, indicating the existence of epigenetic regulatory mechanisms.
650    _2
$a lidé $7 D006801
650    12
$a metabolismus lipidů $7 D050356
650    _2
$a kosterní svalová vlákna $x metabolismus $7 D018485
650    _2
$a kosterní svaly $x metabolismus $7 D018482
650    12
$a myozitida $x metabolismus $7 D009220
650    _2
$a kvalita života $7 D011788
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vernerová, L $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Laiferová, N $u Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia $u Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Balážová, M $u Centre of Biosciences, Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Vokurková, M $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kurdiová, T $u Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia
700    1_
$a Oreská, S $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kubínová, K $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Klein, M $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Špiritović, M $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Physiotherapy, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
700    1_
$a Tomčík, M $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vencovský, J $u Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Ukropec, J $u Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia
700    1_
$a Ukropcová, B $u Biomedical Research Centre, Slovak Academy of Sciences, Institute of Experimental Endocrinology, Bratislava, Slovakia $u Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
773    0_
$w MED00002907 $t The Journal of physiology $x 1469-7793 $g Roč. 599, č. 1 (2021), s. 207-229
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33063873 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101146 $b ABA008
999    __
$a ok $b bmc $g 1690403 $s 1140008
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 599 $c 1 $d 207-229 $e 20201104 $i 1469-7793 $m Journal of physiology (London. Print) $n J Physiol (Lond) $x MED00002907
GRA    __
$a NV16-33574A $p MZ0
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...